Opendata, web and dolomites

C-TCS

A Disruptive Treatment Control Software for Particle Therapy Centers

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 C-TCS project word cloud

Explore the words cloud of the C-TCS project. It provides you a very rough idea of what is the project "C-TCS" about.

roi    facility    facilities    ing    solution    adoption    additional    accelerators    slovenian    puts    annually    radiation    charged       proton    introduction    expensive    building    dose    vendors    financial    times    software    clinical    causes    configurable    radiotherapy    external    universally    diagnosed    globally    cosylab    usable    specializing    custom    costing    25    closed    cancer    delivered    adjustments    sort    proven    narrow    company    surrounding    minimal    men    2025    tissue    centres    damage    death    worldwide    shelf    employ    pt    treatment    manufacturers    healthcare    operation    efficacy    easily    safer    therapy    throughput    17    compact    patients    off    neutron    ion    provides    centre    integrators    100m    positive    beam    slow    lives    lower    limited    types    critical    regarding    nowadays    completion    people    gt    burden    2015    maintenance    tcs    synchronizes    configurability    5x    works    particle    point    costly    alternative    incidences    women    acute   

Project "C-TCS" data sheet

The following table provides information about the project.

Coordinator
COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD 

Organization address
address: GERBIÄŒEVA ULICA 64
city: LJUBLJANA
postcode: 1000
website: http://www.cosylab.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Slovenia [SI]
 Project website https://www.cosylab.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD SI (LJUBLJANA) coordinator 50˙000.00

Map

 Project objective

Cancer is one of the leading causes of death nowadays; 1 in every 2 men and 1 in every 3 women will be diagnosed with cancer at some point of their lives. The number of cancer incidences is growing by 2.4% annually, which puts a financial burden on healthcare systems globally. Particle therapy – PT (proton/neutron/positive ion therapy) has been proven to be effective and a safer alternative to other types of external beam radiotherapy as the charged particle dose is delivered in a narrow range and there is minimal damage to surrounding tissue. In 2015, among all patients that were treated for cancer worldwide, 25% were treated using some sort of radiation. However, building PT centres is very costly (>100M €) which has been a crucial factor in the slow adoption of PT facilities. This is likely to change due to introduction to lower cost/compact systems, and, more importantly, growing clinical evidence regarding its efficacy. A critical part of a PT centre is its treatment control system (TCS), the software that synchronizes the operation of all the devices. Currently, PT centre equipment vendors each custom develop their own TCS, which works only with their own equipment, is of limited configurability, closed to adjustments and expensive. Cosylab is a Slovenian company specializing in the field of control systems for particle accelerators with 17 years of experience in the field. We are developing our TCS (C-TCS) as an off-the-shelf product, that is universally usable on all vendors´ (integrators or manufacturers´) equipment. Our solution is easily configurable, available without lead times, and costing 3-5x-less than custom development. Overall, the C-TCS provides better cancer treatment efficacy, lower production and maintenance cost of PT facility, higher throughput of patients (resulting in more people treated). In 5 years after completion of the project (2025) we expect to employ additional 20 people and achieve a ROI of 5.6.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "C-TCS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "C-TCS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More